Literature DB >> 20558827

Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance.

Linda W van Laake1, Li Qian, Paul Cheng, Yu Huang, Edward C Hsiao, Bruce R Conklin, Deepak Srivastava.   

Abstract

RATIONALE: Induced pluripotent stem (iPS) cells can differentiate into multiple cell types, including cardiomyocytes and have tremendous potential for drug discovery and regenerative therapies. However, it is unknown how much variability exists between differentiated lineages from independent iPS cell lines and, specifically, how similar iPS cell-derived cardiomyocytes (iPS-CMs) are to embryonic stem (ES) cell-derived cardiomyocytes (ES-CMs).
OBJECTIVE: We investigated how much variability exists between differentiated lineages from independent iPS cell lines and how similar iPS-CMs are to ES-CMs. METHODS AND
RESULTS: We generated mouse iPS cells in which expression of NKX2-5, an early cardiac transcription factor, was marked by transgenic green fluorescent protein (GFP). Isolation of iPS- and ES-derived NKX2-5-GFP(+) cardiac progenitor pools, marked by identical reporters, revealed unexpectedly high similarity in genome-wide mRNA expression levels. Furthermore, the variability between cardiac progenitors derived from independent iPS lines was minimal. The NKX2-5-GFP(+) iPS cells formed cardiomyocytes by numerous induction protocols and could survive upon transplantation into the infarcted mouse heart without formation of teratomas.
CONCLUSIONS: Despite the line-to-line variability of gene expression in the undifferentiated state of ES and iPS cells, the variance narrows significantly in lineage-specific iPS-derived cardiac progenitors, and these progenitor cells can be isolated and used for transplantation without generation of unwanted cell types.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558827      PMCID: PMC2919280          DOI: 10.1161/CIRCRESAHA.109.215434

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.

Authors:  Christine Mummery; Dorien Ward-van Oostwaard; Pieter Doevendans; Rene Spijker; Stieneke van den Brink; Rutger Hassink; Marcel van der Heyden; Tobias Opthof; Martin Pera; Aart Brutel de la Riviere; Robert Passier; Leon Tertoolen
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

2.  F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses.

Authors:  William T Poueymirou; Wojtek Auerbach; David Frendewey; Joseph F Hickey; Jennifer M Escaravage; Lakeisha Esau; Anthony T Doré; Sean Stevens; Niels C Adams; Melissa G Dominguez; Nicholas W Gale; George D Yancopoulos; Thomas M DeChiara; David M Valenzuela
Journal:  Nat Biotechnol       Date:  2006-12-24       Impact factor: 54.908

3.  Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification.

Authors:  Alessandra Moretti; Leslie Caron; Atsushi Nakano; Jason T Lam; Alexandra Bernshausen; Yinhong Chen; Yibing Qyang; Lei Bu; Mika Sasaki; Silvia Martin-Puig; Yunfu Sun; Sylvia M Evans; Karl-Ludwig Laugwitz; Kenneth R Chien
Journal:  Cell       Date:  2006-11-22       Impact factor: 41.582

4.  Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors.

Authors:  Chulan Kwon; Joshua Arnold; Edward C Hsiao; Makoto M Taketo; Bruce R Conklin; Deepak Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-18       Impact factor: 11.205

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages.

Authors:  Steven J Kattman; Tara L Huber; Gordon M Keller
Journal:  Dev Cell       Date:  2006-11       Impact factor: 12.270

7.  Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart.

Authors:  Sean M Wu; Yuko Fujiwara; Susan M Cibulsky; David E Clapham; Ching-Ling Lien; Thomas M Schultheiss; Stuart H Orkin
Journal:  Cell       Date:  2006-11-22       Impact factor: 41.582

8.  Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.

Authors:  Marjorie Pick; Yonatan Stelzer; Ori Bar-Nur; Yoav Mayshar; Amir Eden; Nissim Benvenisty
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

9.  Induction of pluripotent stem cells from fibroblast cultures.

Authors:  Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Shinya Yamanaka
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

10.  Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction.

Authors:  Linda W van Laake; Robert Passier; Jantine Monshouwer-Kloots; Marcel G Nederhoff; Dorien Ward-van Oostwaard; Loren J Field; Cees J van Echteld; Pieter A Doevendans; Christine L Mummery
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more
  30 in total

1.  Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.

Authors:  Nan Cao; Zumei Liu; Zhongyan Chen; Jia Wang; Taotao Chen; Xiaoyang Zhao; Yu Ma; Lianju Qin; Jiuhong Kang; Bin Wei; Liu Wang; Ying Jin; Huang-Tian Yang
Journal:  Cell Res       Date:  2011-12-06       Impact factor: 25.617

2.  End of inevitability: programming and reprogramming.

Authors:  Kursad Turksen
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 3.  Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.

Authors:  Pieterjan Dierickx; Pieter A Doevendans; Niels Geijsen; Linda W van Laake
Journal:  J Cardiovasc Transl Res       Date:  2012-07-18       Impact factor: 4.132

4.  Microfluidic organs-on-chips.

Authors:  Sangeeta N Bhatia; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 5.  Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.

Authors:  Inbar Budniatzky; Lior Gepstein
Journal:  Stem Cells Transl Med       Date:  2014-03-03       Impact factor: 6.940

Review 6.  Functional cardiac tissue engineering.

Authors:  Brian Liau; Donghui Zhang; Nenad Bursac
Journal:  Regen Med       Date:  2012-03       Impact factor: 3.806

7.  Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar.

Authors:  Manoj K Gupta; Damir J Illich; Andrea Gaarz; Matthias Matzkies; Filomain Nguemo; Kurt Pfannkuche; Huamin Liang; Sabine Classen; Michael Reppel; Joachim L Schultze; Jürgen Hescheler; Tomo Sarić
Journal:  BMC Dev Biol       Date:  2010-09-15       Impact factor: 1.978

8.  Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.

Authors:  Hongran Wang; Yutao Xi; Yi Zheng; Xiaohong Wang; Austin J Cooney
Journal:  Stem Cell Res       Date:  2016-02-23       Impact factor: 2.020

Review 9.  Induced pluripotent stem cells for cardiac repair.

Authors:  Limor Zwi-Dantsis; Lior Gepstein
Journal:  Cell Mol Life Sci       Date:  2012-07-20       Impact factor: 9.261

10.  The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.

Authors:  Ana M Martins; Gordana Vunjak-Novakovic; Rui L Reis
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.